retatrutide nonalcoholic fatty liver disease trial nash Researchers report promising results with retatrutide, which significantly reduced fat in some patients over several months. Excess liver fat causes metabolic dysfunction–associated steatotic retatrutide nonalcoholic fatty liver disease

Thus, patients treated with liraglutide reported reduced alcohol intake compared to patients who received other diabetic treatments ( GLP-1R gene ( GLP-1R polymorphisms are associated with higher breath concentrations of alcohol and increased intravenous infusion of alcohol in social drinkers (Tsermpini et al., 2022)

Proton pump inhibitors (PPIs) help relieve symptoms of GERD and stomach ulcers

People who take advantage of this period to build sustainable habits are better equipped to manage their weight after the medication is discontinued

We dont just prescribe a medication and send you home we partner with you throughout your weight loss journey, providing the medical supervision, lifestyle coaching, and ongoing support needed to achieve and sustain real results